Skip to content

GLPG

Galapagos NV

NASDAQ · Healthcare · Biotechnology · BE

$27.98
+1.71%
Ask drillr

Latest reported

Last report date
May 7, 2026
EPS actual
$0.25
EPS estimate
-$1.27
Revenue actual
$9.0M
Revenue estimate
$11.3M

Track record

Trailing twelve quarters

EPS beats (12Q)
8
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-683.2%
Revenue beats (12Q)
6
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
May 7, 2026-$1.27$0.25Beat 119.69%$9.0M
Nov 5, 2025-$0.20-$3.59Miss -1696.35%$83.3M
Jul 23, 2025-$0.67-$1.89Miss -182.27%$76.9M
Apr 23, 2025-$0.23-$2.47Miss -973.91%$82.2M
Feb 28, 2025-$0.24$0.39Beat 263.33%$78.2M
Oct 30, 2024-$0.27-$0.77Miss -185.19%$65.6M
Sep 12, 2024$0.03$0.14Beat 450.10%$83.7M
May 2, 2024-$0.12$0.39Beat 425.00%$67.1M
Feb 23, 2024-$1.18$2.39Beat 302.54%-$230.0M
Nov 3, 2023-$0.62$0.39Beat 162.90%$126.6M
Aug 3, 2023-$0.70$0.08Beat 111.43%$163.6M
May 4, 2023-$0.87$0.43Beat 149.43%$194.5M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 7, 2026